Polo-like kinase and survivin are esophageal tumor-specific promoters
- 7 April 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 342 (2) , 465-471
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Survivin-Responsive Conditionally Replicating Adenovirus Exhibits Cancer-Specific and Efficient Viral ReplicationCancer Research, 2005
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- A Cox-2 Promoter-Based Replication-Selective Adenoviral Vector to Target the Cox-2-Expressing Human Bladder Cancer CellsClinical Cancer Research, 2004
- Polo-like kinases and the orchestration of cell divisionNature Reviews Molecular Cell Biology, 2004
- Adenovirus-Mediated p14
ARF
Gene Transfer Cooperates with Ad5CMV-p53 to Induce Apoptosis in Human Cancer CellsHuman Gene Therapy, 2002
- Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variationNucleic Acids Research, 2002
- Tumor-specific transcriptional targeting of suicide gene therapyGene Therapy, 2002
- VEGF165antisense RNA suppresses oncogenic properties of human esophageal squamous cell carcinomaWorld Journal of Gastroenterology, 2002
- Preclinical Study of Adenoviral p53 Gene Therapy for Esophageal CancerSurgery Today, 2001
- Characterization of 21 newly established esophageal cancer cell linesCancer, 1992